Cosmos Holdings Inc. Common Stock

COSM

Cosmos Holdings Inc. (COSM) is a diversified company engaged in the acquisition, development, and commercialization of consumer brands and related businesses. The company focuses on building a portfolio of innovative products across various sectors, including health and wellness, consumer goods, and other lifestyle categories.

$0.23 -0.04 (-13.75%)
🚫 Cosmos Holdings Inc. Common Stock does not pay dividends

Company News

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio
Benzinga • Na • June 11, 2026

Cosmos Health Inc. (NASDAQ: COSM) announced a non-binding letter of intent to acquire 100% of Doc Pharma S.A., a European GMP-licensed pharmaceutical manufacturer. The acquisition is expected to be immediately accretive, expanding Cosmos Health's asset base by approximately $24 million, adding $6.7 million in average annual revenue and $3.2 milli...

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
GlobeNewswire Inc. • Greg Siokas • October 10, 2025

Cosmos Health Inc. purchased an additional $500,000 in Ethereum, bringing its total investment to $1.5 million under its $300 million digital assets facility, aiming to diversify its balance sheet and explore blockchain technology in healthcare.

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units
GlobeNewswire Inc. • Greg Siokas • October 3, 2025

Cosmos Health's subsidiary SkyPharm signed an exclusive distribution agreement with Diyar United to market Sky Premium Life nutraceuticals in Kuwait, securing an initial purchase order of over 65,000 units in a market projected to reach $1.68 billion by 2030.

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
GlobeNewswire Inc. • Greg Siokas • September 22, 2025

Cosmos Health enters the U.S. nutraceuticals market with its Sky Premium Life brand, launching NOOR Collagen and expecting 75% gross margins and over $12M in annualized revenue from the product.

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
GlobeNewswire Inc. • Greg Siokas • September 11, 2025

Cosmos Health signed a distribution agreement with Scientific Pharmacy in Oman for Sky Premium Life food supplements, securing an initial purchase order of 42,000 units in the rapidly growing $7 billion GCC nutraceuticals market.

Related Companies